dc.contributor.author | Trammell, Sara | eng |
dc.contributor.author | Shakil, Amer | eng |
dc.contributor.author | Wilder, Laura | eng |
dc.date.issued | 2005 | eng |
dc.description.abstract | When the standard therapies -- mild topical
corticosteroids and moisturizers -- fail in the
treatment of atopic dermatitis, patients are left with few proven remedies. The recently introduced topical immunosuppressive treatment --pimecrolimus and tacrolimus -- offer an alternative to topical corticosteroids.
Tacrolimus 0.1% (Protopic) appears to be both
safe and effective in treating eczema in adults and children (strength of recommendation [SOR]: A). In multiple studies, it has been as effective as potent
topical corticosteroids and more effective than mild topical corticosteroids (SOR: A).
Pimecrolimus (Elidel) is more effective than
placebo but less effective than potent topical corticosteroids (SOR: A). At this time, no data compare pimecrolimus with mild corticosteroids. | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3381 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2005 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 54, no. 08 (August 2005) | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | eczema | eng |
dc.subject | topical immunosuppressant | eng |
dc.subject | corticosteroids | eng |
dc.subject.lcsh | Atopic dermatitis | eng |
dc.subject.lcsh | Eczema | eng |
dc.subject.lcsh | Adrenocortical hormones | eng |
dc.subject.lcsh | FK-506 (Drug) | eng |
dc.title | What is the role of tacrolimus and pimecrolimus in atopic dermatitis? | eng |
dc.type | Article | eng |